Martine Bagot Selected Research

mogamulizumab

1/2022	Dermatologic Events Associated with the Anti-CCR4 Antibody Mogamulizumab: Characterization and Management.
1/2022	Mogamulizumab induces long-term immune restoration and reshapes tumour heterogeneity in Sézary syndrome.
1/2022	Long-term disease control and safety with the anti-CCR4 antibody mogamulizumab: Post-hoc analyses from the MAVORIC trial of patients with previously treated cutaneous T-cell lymphoma.
1/2022	Head and neck granulomatous rash associated with mogamulizumab mimicking mycosis fungoides.
1/2022	Macrophage-derived CXCL9 and CXCL11, T-cell skin homing, and disease control in mogamulizumab-treated CTCL patients.
12/2021	Lack of impact of type and extent of prior therapy on outcomes of mogamulizumab therapy in patients with cutaneous T cell lymphoma in the MAVORIC trial.
10/2021	Granulomatous rash associated with mogamulizumab mimicking mycosis fungoides: a case series.
10/2021	Is mogamulizumab-induced alopecia areata associated with favorable outcomes in Sézary syndrome?
4/2021	Mogamulizumab-induced vitiligo in patients with Sézary syndrome: three cases.
1/2021	Quality of Life Effect of the Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Vorinostat in Patients With Cutaneous T-cell Lymphoma.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martine Bagot Research Topics

Disease

25	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 11/2022 - 01/2004
24	Melanoma (Melanoma, Malignant) 12/2018 - 10/2006
21	Neoplasms (Cancer) 01/2022 - 12/2003
17	Mycosis Fungoides 01/2022 - 09/2005
7	Lymphoma (Lymphomas) 11/2020 - 06/2006
7	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020 - 05/2004
5	Exanthema (Rash) 01/2022 - 09/2012
5	Stevens-Johnson Syndrome (Lyell's Syndrome) 06/2019 - 04/2002
4	Localized Scleroderma (Morphea) 10/2022 - 02/2011
4	Cutaneous Lupus Erythematosus 01/2022 - 12/2014
4	Inflammation (Inflammations) 04/2021 - 01/2016
4	Sarcoidosis (Schaumann Disease) 01/2020 - 01/2012
4	Skin Diseases (Skin Disease) 01/2016 - 09/2013
4	Blister (Bulla) 02/2011 - 04/2002
3	Atopic Dermatitis (Atopic Eczema) 01/2021 - 11/2014
3	Disease Progression 11/2020 - 09/2007
3	Paraproteinemias (Monoclonal Gammopathy) 01/2020 - 06/2013
3	Pyoderma Gangrenosum 04/2019 - 01/2016
3	Pain (Aches) 12/2018 - 09/2013
3	Infections 01/2018 - 02/2015
3	Hypersensitivity (Allergy) 06/2017 - 01/2012
3	Exfoliative Dermatitis (Erythroderma) 06/2015 - 02/2008
3	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2012 - 02/2007
2	Tinea (Ringworm) 01/2022 - 02/2015
2	Vasculitis (Vasculitides) 01/2022 - 02/2015
2	Urticaria (Hives) 04/2021 - 01/2019
2	Scleromyxedema (Lichen Myxedematosus) 01/2020 - 06/2013
2	Necrobiosis Lipoidica 01/2020 - 01/2019
2	Bullous Pemphigoid (Pemphigoid) 06/2019 - 01/2010
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2018 - 11/2017
2	Sepsis (Septicemia) 01/2018 - 02/2015
2	Sezary Syndrome (Sezary Erythroderma) 03/2017 - 06/2007
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 03/2017 - 06/2010
2	Neoplasm Metastasis (Metastasis) 08/2016 - 02/2014
2	Carcinogenesis 08/2016 - 02/2009
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2016 - 01/2016
2	Granuloma Annulare 02/2016 - 02/2011
2	Diarrhea 01/2016 - 06/2013
2	Crohn Disease (Crohn's Disease) 01/2016 - 02/2007
2	Colitis 01/2016 - 06/2013
2	Bronchiolitis Obliterans Syndrome 07/2015 - 03/2015
2	Burns 02/2011 - 11/2004
1	Lichen Planus (Lichen Ruber Planus) 10/2022
1	Benign Familial Pemphigus (Hailey Hailey Disease) 05/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022
1	Contact Dermatitis (Eczema, Contact) 01/2022

Drug/Important Bio-Agent (IBA)

12	mogamulizumabIBA 01/2022 - 03/2017
10	Monoclonal AntibodiesIBA 01/2022 - 03/2012
8	AntibodiesIBA 01/2021 - 04/2007
7	Pharmaceutical PreparationsIBA 01/2022 - 04/2002
7	Infliximab (Remicade)FDA Link 01/2019 - 02/2007
6	Rituximab (Mabthera)FDA Link 01/2018 - 03/2009
6	IpilimumabIBA 01/2017 - 06/2013
5	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 09/2005
5	VemurafenibIBA 10/2017 - 10/2012
5	Biomarkers (Surrogate Marker)IBA 11/2016 - 03/2012
5	Proteins (Proteins, Gene)FDA Link 05/2016 - 05/2004
4	Vorinostat FDA Link 01/2022 - 01/2018
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2019 - 11/2004
4	CytokinesIBA 11/2018 - 11/2004
4	Immune Checkpoint InhibitorsIBA 11/2017 - 05/2016
4	NivolumabIBA 11/2017 - 05/2016
4	SteroidsIBA 02/2017 - 06/2013
4	Biological ProductsIBA 11/2015 - 05/2011
4	plastinIBA 01/2014 - 02/2008
3	Mechlorethamine (Nitrogen Mustard)FDA Link 01/2022 - 09/2005
3	InterferonsIBA 01/2022 - 02/2011
3	Immunoglobulin A (IgA)IBA 04/2021 - 09/2013
3	LigandsIBA 01/2021 - 02/2009
3	KIR3DL2 ReceptorsIBA 08/2018 - 10/2014
3	PerforinIBA 02/2009 - 04/2002
3	AntigensIBA 02/2009 - 12/2003
2	RNA (Ribonucleic Acid)IBA 10/2022 - 10/2021
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022 - 09/2020
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022 - 04/2002
2	EnzymesIBA 11/2021 - 05/2011
2	dupilumabIBA 01/2021 - 09/2020
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2020 - 06/2015
2	Etanercept (Enbrel)FDA Link 01/2019 - 02/2007
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2019 - 01/2016
2	CalciumIBA 12/2018 - 01/2014
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2018 - 10/2017
2	Interleukin-2 (IL2)IBA 01/2018 - 12/2005
2	Lenalidomide (CC 5013)FDA Link 01/2018 - 06/2017
2	liposomal doxorubicin (Doxil)FDA Link 06/2017 - 11/2012
2	pembrolizumabIBA 01/2017 - 01/2016
2	Interleukin-17 (Interleukin 17)IBA 08/2016 - 12/2012
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2016 - 03/2013
2	Phosphotransferases (Kinase)IBA 12/2015 - 02/2006
2	AllergensIBA 01/2015 - 11/2014
2	Interferon-gamma (Interferon, gamma)IBA 06/2010 - 11/2004
1	Triggering Receptor Expressed on Myeloid Cells-1IBA 10/2022
1	Naltrexone (ReVia)FDA LinkGeneric 05/2022
1	Terbinafine (Lamisil)FDA LinkGeneric 01/2022

Therapy/Procedure

24	Therapeutics 11/2022 - 09/2005
9	Immunotherapy 01/2018 - 06/2010
6	Drug Therapy (Chemotherapy) 11/2020 - 03/2009
3	Combination Drug Therapy (Combination Chemotherapy) 01/2018 - 05/2014
3	Stem Cell Transplantation 02/2017 - 03/2014
2	Hematopoietic Stem Cell Transplantation 10/2020 - 07/2015